His main research concerns Cell culture, Biochemistry, In vitro, Microfluidics and Nanotechnology. His Cell culture research incorporates elements of Cell, Virology, Molecular biology, Toxicity and Cell biology. The concepts of his Biochemistry study are interwoven with issues in Paclitaxel, Taxoid and Taxus.
His study in In vitro is interdisciplinary in nature, drawing from both Ferritin, Bioavailability, Mucin and Mucus. His Microfluidics research is multidisciplinary, incorporating perspectives in Membrane, Chemotaxis, Biomedical engineering and Analytical chemistry. His Nanotechnology study combines topics from a wide range of disciplines, such as Synthetic membrane, Biophysics, Drug development and In vivo.
His primary areas of study are Cell culture, Biochemistry, Bioreactor, Cell and Cell biology. Michael L. Shuler interconnects In vitro, Recombinant DNA, Cell growth, Biophysics and Molecular biology in the investigation of issues within Cell culture. Many of his studies on Biochemistry involve topics that are commonly interrelated, such as Taxus.
His Bioreactor research integrates issues from Chromatography and Chemical engineering. His Escherichia coli research includes themes of Microbiology and Bacteria. As a part of the same scientific family, Michael L. Shuler mostly works in the field of Bacteria, focusing on Enterobacteriaceae and, on occasion, Plasmid.
Michael L. Shuler mainly focuses on Drug development, Cell culture, Nanotechnology, In vitro and Drug. The Drug development study combines topics in areas such as Organ system, Drug discovery, Physiologically based pharmacokinetic modelling and Biochemical engineering. His Cell culture research is multidisciplinary, relying on both Membrane, Liver tissue, Liver cell, Tight junction and Bone marrow.
The various areas that he examines in his Nanotechnology study include Cell and In vivo. His work carried out in the field of In vitro brings together such families of science as Adhesion, Immunology, Biomedical engineering and Equivalent. His Drug research includes elements of Pharmacokinetics, Inhalation, Organ-on-a-chip and Toxicity.
Michael L. Shuler mainly investigates Drug development, In vitro, Cell culture, Drug and Biomedical engineering. His studies deal with areas such as Nanotechnology, Biochemical engineering, Physiologically based pharmacokinetic modelling, Organ system and Drug discovery as well as Drug development. Michael L. Shuler combines subjects such as Urea, Barrier function, Andrology, Albumin and Liver tissue with his study of In vitro.
His research investigates the connection with Cell culture and areas like Liver cell which intersect with concerns in Interleukin 8, Biochemistry, Shear stress and Hepatic stellate cell. His research in Drug intersects with topics in Animal data, Organ-on-a-chip and Bioinformatics. His Biomedical engineering research incorporates elements of Fluidic channel, Microfluidics, Membrane, Compartment and Tight junction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bioprocess Engineering: Basic Concepts
Michael L. Shuler;Fikret Kargı;Matthew DeLisa.
TEER Measurement Techniques for In Vitro Barrier Model Systems
Balaji Srinivasan;Aditya Reddy Kolli;Mandy Brigitte Esch;Hasan Erbil Abaci.
Journal of Laboratory Automation (2015)
Integration of cell culture and microfabrication technology.
Tai Hyun Park;Michael L. Shuler.
Biotechnology Progress (2003)
Taxol®: science and applications.
M. Suffness;M. E. Wall;H. R. Hartzell;E. M. Croom.
A microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip
Jong Hwan Sung;Carrie Kam;Michael L. Shuler.
Lab on a Chip (2010)
The kinetics of taxoid accumulation in cell suspension cultures of Taxus following elicitation with methyl jasmonate
Raymond E. B. Ketchum;Donna M. Gibson;Rodney B. Croteau;Michael L. Shuler.
Biotechnology and Bioengineering (1999)
A micro cell culture analog (µCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs
Jong Hwan Sung;Michael L. Shuler.
Lab on a Chip (2009)
A hydrogel-based microfluidic device for the studies of directed cell migration
Shing-Yi Cheng;Steven Heilman;Max Wasserman;Shivaun Archer.
Lab on a Chip (2007)
The Design and Fabrication of Three‐Chamber Microscale Cell Culture Analog Devices with Integrated Dissolved Oxygen Sensors
Aaron Sin;Katherine C. Chin;Muhammad F. Jamil;Yordan Kostov.
Biotechnology Progress (2008)
Development of a microscale cell culture analog to probe naphthalene toxicity.
Kwanchanok Viravaidya;Aaron Sin;Michael L. Shuler.
Biotechnology Progress (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: